Activity Overview
Rheum2Learn 2.0 is case-based, fundamental clinical rheumatology education for residents. Each interactive activity includes three patient cases that focus on the care and assessment of individuals with rheumatologic diseases.
Learn about the diverse nature of scleroderma and how it can affect multiple organ systems. The cases in this activity discuss Raynaud’s phenomenon, cutaneous manifestations of systemic sclerosis, and scleroderma renal crisis (SRC).
Rheum2Learn 2.0 Series
This activity is part of a series. See all activities in the series below.
Target Audience
Residents in training who may provide care for patients with rheumatic diagnoses in primary care, inpatient, critical care, and other clinical contexts.
The activity may also be of interest to medical students, fellows in training, advanced practice providers, practicing physicians, and other health care professionals who seek to strengthen their clinical knowledge of rheumatic diseases.
Learning Objectives
Upon completion of this activity, participants should be able to:
Identify the differential diagnosis and appropriate workup for primary versus secondary Raynaud’s phenomenon
Interpret the 2013 ACR/EULAR classification criteria for systemic sclerosis (SSc) and apply it to a patient case
Distinguish limited vs. diffuse systemic sclerosis based on the extent of skin involvement
Identify first line pharmacologic and non-pharmacologic treatments for Raynaud’s phenomenon and cutaneous manifestations of systemic sclerosis
Review the differential diagnosis for shortness of breath in a patient with systemic sclerosis
Highlight cardiopulmonary disease (interstitial lung disease and pulmonary arterial hypertension) as the major causes of mortality in systemic sclerosis
Describe risk factors associated with an increased risk for scleroderma renal crisis (SRC)
Review the typical clinical presentation and laboratory findings of scleroderma renal crisis for diagnosis and prognosis
Outline the approach to the treatment of scleroderma renal crisis emphasizing prompt need to control blood pressure with ACE inhibitor therapy
Understand the implications of scleroderma renal crisis on prognosis in systemic sclerosis
Price
Registration is complimentary.
Credit Information
This activity is not eligible for credit.
Acknowledgement of Commercial Support
No commercial support was provided for this activity.
Educational Activity Policies
See ACR educational activity policies, including the online enduring activity refund policy.